Perifar SCRL
1.0 FTEPerifar reported total assets of €1.33m at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Jun 2026), with 1 full-time equivalent.
The score of Perifar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +44 % Total assets +42 % Headcount (avg FTE) -33 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Perifar's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 04 Jul 2025
- Year ended 31 Dec 2023filed on 17 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jul 2022
Perifar's financial analysis
- Solvency93.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Perifar
Perifar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0432.559.325
- VAT number
- BE0432559325
- Peppol
- Registered · 0208:0432559325 · as of 10 Nov 2026
- Legal form
- SCRL
- Incorporated
- 25 Nov 1987
- Registered office
- 2100 Antwerp
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Perifar (SCRL) has been based in Antwerp since 1987, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 118,986 € and equity of €1.25m; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 93.9%, above the median of its sector (44.2%).
Companies similar to Perifar
Companies in the same business, of comparable size and area, outside its group.
- AFS Retail sale of pharmaceutical products Antwerp · balance sheet €22.0m
- Zorg EN Meer Retail sale of medical and orthopaedic goods Ghent · balance sheet 751,356 €
- Apotheek Bijnens Centrum Retail sale of pharmaceutical products Genk · balance sheet 759,851 €
- Vitacura Retail sale of other food Liège · balance sheet 713,142 €
- Pharmacie populaire La Sauvegarde Retail sale of pharmaceutical products Soumagne · balance sheet €5.64m
- Warvan Retail sale of pharmaceutical products Waregem · balance sheet 251,999 €
- Geassocieerde Apotheek DE Ridder Retail sale of pharmaceutical products Ninove · balance sheet 231,024 €
- Apotheken Solidaris Retail sale of pharmaceutical products Hasselt · balance sheet €8.84m
Frequently asked questions about Perifar
What is the revenue of Perifar?
Perifar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Perifar?
In Belgium, the VAT number is the company number prefixed with BE: BE0432559325 for Perifar, if the company is VAT-registered. Its company number (CBE) is 0432.559.325.
Where is the registered office of Perifar?
According to the CBE register, the registered office of Perifar is in 2100 Antwerp.
What is the equity of Perifar?
At the close of the 2025 financial year, the equity of Perifar amounts to 1,247,625 €, a solvency of 93.9% of total assets.
How many people work at Perifar?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Perifar?
The register lists 2 active mandates at Perifar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Perifar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →